- Home
- KLTO vs AEON Comparison
KLTO vs AEON Comparison
Compare KLTO & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- AEON
- Stock Information
- Founded
- KLTO 2019
- AEON N/A
- Country
- KLTO United States
- AEON United States
- Employees
- KLTO N/A
- AEON N/A
- Industry
- KLTO
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- KLTO
- AEON Health Care
- Exchange
- KLTO NYSE
- AEON Nasdaq
- Market Cap
- KLTO 4.8M
- AEON 4.2M
- IPO Year
- KLTO N/A
- AEON N/A
- Fundamental
- Price
- KLTO $0.22
- AEON $0.50
- Analyst Decision
- KLTO
- AEON Strong Buy
- Analyst Count
- KLTO 0
- AEON 1
- Target Price
- KLTO N/A
- AEON $360.00
- AVG Volume (30 Days)
- KLTO 31.8M
- AEON 299.6K
- Earning Date
- KLTO 05-15-2025
- AEON 05-14-2025
- Dividend Yield
- KLTO N/A
- AEON N/A
- EPS Growth
- KLTO N/A
- AEON N/A
- EPS
- KLTO N/A
- AEON 73.23
- Revenue
- KLTO N/A
- AEON N/A
- Revenue This Year
- KLTO N/A
- AEON N/A
- Revenue Next Year
- KLTO N/A
- AEON N/A
- P/E Ratio
- KLTO N/A
- AEON $0.01
- Revenue Growth
- KLTO N/A
- AEON N/A
- 52 Week Low
- KLTO $0.11
- AEON $0.38
- 52 Week High
- KLTO $13.10
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- AEON 36.32
- Support Level
- KLTO N/A
- AEON $0.47
- Resistance Level
- KLTO N/A
- AEON $0.52
- Average True Range (ATR)
- KLTO 0.00
- AEON 0.04
- MACD
- KLTO 0.00
- AEON 0.07
- Stochastic Oscillator
- KLTO 0.00
- AEON 61.93
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.